Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 5
2020 2
2021 1
2022 6
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting.
Attardi E, Savi A, Borsellino B, Piciocchi A, Cipriani M, Ottone T, Fabiani E, Divona M, Travaglini S, Pascale MR, Awada H, Durmaz A, Visconte V, Della Porta MG, Venditti A, Maciejewski JP, Gurnari C, Voso MT. Attardi E, et al. Among authors: travaglini s. Blood Adv. 2023 Sep 12;7(17):5122-5131. doi: 10.1182/bloodadvances.2023010173. Blood Adv. 2023. PMID: 37327116 Free PMC article.
Retinoic acid and proteotoxic stress induce AML cell death overcoming stromal cell protection.
Liccardo F, Śniegocka M, Tito C, Iaiza A, Ottone T, Divona M, Travaglini S, Mattei M, Cicconi R, Miglietta S, Familiari G, Nottola SA, Petrozza V, Tamagnone L, Voso MT, Masciarelli S, Fazi F. Liccardo F, et al. Among authors: travaglini s. J Exp Clin Cancer Res. 2023 Aug 31;42(1):223. doi: 10.1186/s13046-023-02793-z. J Exp Clin Cancer Res. 2023. PMID: 37653435 Free PMC article.
MCL1 regulates AML cells metabolism via direct interaction with HK2. Metabolic signature at onset predicts overall survival in AMLs' patients.
Catalano G, Zaza A, Banella C, Pelosi E, Castelli G, de Marinis E, Smigliani A, Travaglini S, Ottone T, Divona M, Del Principe MI, Buccisano F, Maurillo L, Ammatuna E, Testa U, Nervi C, Venditti A, Voso MT, Noguera NI. Catalano G, et al. Among authors: travaglini s. Leukemia. 2023 Aug;37(8):1600-1610. doi: 10.1038/s41375-023-01946-5. Epub 2023 Jun 22. Leukemia. 2023. PMID: 37349598
Vitamin C Deficiency in Patients With Acute Myeloid Leukemia.
Ottone T, Faraoni I, Fucci G, Divona M, Travaglini S, De Bellis E, Marchesi F, Angelini DF, Palmieri R, Gurnari C, Giansanti M, Nardozza AM, Montesano F, Fabiani E, Lindfors Rossi EL, Cerretti R, Cicconi L, De Bardi M, Catanoso ML, Battistini L, Massoud R, Venditti A, Voso MT. Ottone T, et al. Among authors: travaglini s. Front Oncol. 2022 Jun 27;12:890344. doi: 10.3389/fonc.2022.890344. eCollection 2022. Front Oncol. 2022. PMID: 35832559 Free PMC article.
Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment.
Banella C, Catalano G, Travaglini S, Pelosi E, Ottone T, Zaza A, Guerrera G, Angelini DF, Niscola P, Divona M, Battistini L, Screnci M, Ammatuna E, Testa U, Nervi C, Voso MT, Noguera NI. Banella C, et al. Among authors: travaglini s. Cancers (Basel). 2022 May 23;14(10):2565. doi: 10.3390/cancers14102565. Cancers (Basel). 2022. PMID: 35626170 Free PMC article.
CD99 as a novel therapeutic target on leukemic progenitor cells in FLT3-ITDmut AML.
Travaglini S, Ottone T, Angelini DF, Fiori V, Dominici S, Noguera NI, Śniegocka M, Antonelli S, Irno Consalvo MA, De Bardi M, Banella C, Divona M, Marchesi F, Masciarelli S, Fazi F, Pieraccioli M, Palmieri R, De Angelis G, Buccisano F, Venditti A, Battistini L, Magnani M, Voso MT. Travaglini S, et al. Leukemia. 2022 Jun;36(6):1685-1688. doi: 10.1038/s41375-022-01566-5. Epub 2022 Apr 14. Leukemia. 2022. PMID: 35422094 No abstract available.
YY1 Knockdown Relieves the Differentiation Block and Restores Apoptosis in AML Cells.
Noguera NI, Travaglini S, Scalea S, Catalanotto C, Reale A, Zampieri M, Zaza A, Ricciardi MR, Angelini DF, Tafuri A, Ottone T, Voso MT, Zardo G. Noguera NI, et al. Among authors: travaglini s. Cancers (Basel). 2023 Aug 7;15(15):4010. doi: 10.3390/cancers15154010. Cancers (Basel). 2023. PMID: 37568827 Free PMC article.
PML/RARA inhibits expression of HSP90 and its target AKT.
Piredda ML, Gaur G, Catalano G, Divona M, Banella C, Travaglini S, Puzzangara MC, Voso MT, Lo-Coco F, Noguera NI. Piredda ML, et al. Among authors: travaglini s. Br J Haematol. 2019 Mar;184(6):937-948. doi: 10.1111/bjh.15715. Epub 2018 Dec 9. Br J Haematol. 2019. PMID: 30536958 Free article.
21 results